Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers Post hoc analysis published in Advances in Wound Care,...
-
Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Canine Orthopedics Market Size, Trends and Insights By Product Type (Implants...
-
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the launch...
-
Thomann steps into the COO role as iHerb accelerates its domestic and international delivery capabilities to meet rising global demand.
-
Franklin, TN, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Doctors at Optique Franklin, optometrists in Franklin TN who offer personalized, high-quality vision care in an inviting, boutique-style setting, are...
-
Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Digital Mammography Market Size, Trends and Insights By Technology (2D Full...
-
Washington, DC, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/08/08/week-29-of-americas-shining-success/ ThinkCareBelieve has...
-
LOS ANGELES, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Limitless X Holdings, Inc. (OTCQB: LIMX), a company dedicated to inspiring and empowering individuals while also maximizing shareholder value through a...
-
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting...
-
– 94% reduction in HSV-2 shedding rate and 98% reduction in high viral load shedding rate, both statistically significant, observed in cohort evaluating 350 mg weekly oral dose compared to placebo...